Literature DB >> 31557135

Causes of delays in breast cancer diagnosis in Poland.

Elżbieta Cipora1, Magdalena Konieczny1, Aleksandra Czerw2, Marcin Mikos3, Michał Piotr Budzik4, Andrzej Deptała4, Anna Maria Badowska-Kozakiewicz4.   

Abstract

Breast cancer is the most common malignant tumor in women. The results of breast cancer treatment to a large extent depend on the time of the primary diagnosis of the disease. AIM: The aim of this study was to determine the most common causes of the delay and the delay time in the diagnosis of breast cancer in Polish women.
MATERIALS AND METHODS: The study was performed using a diagnostic survey and analysis of medical documentation from the Subcarpathian Regional Oncology Center, Poland. A total of 231 patients with diagnosed breast cancer were recruited to the study.
RESULTS: Delays in diagnosing of breast cancer were found in 83.1% of all the patients. The average time from the first symptom observation by a woman to the first medical consultation was on average 61.7 days. The most common cause of the delay in medical consultation in the examined group was a fear of diagnosing cancer (31.2%).
CONCLUSIONS: The examined women require permanent health education in the field of breast cancer and the importance of early diagnosis of the disease for the effectiveness of treatment and prognosis.
© 2019 MEDPRESS.

Entities:  

Keywords:  breast cancer; cancer prevention; diagnostics; early detection

Mesh:

Year:  2019        PMID: 31557135

Source DB:  PubMed          Journal:  Pol Merkur Lekarski        ISSN: 1426-9686


  2 in total

1.  Advancing Breast Cancer Advocacy in Eastern Europe and Central Asia: Findings From Women's Empowerment Cancer Advocacy Network (WE CAN) Summits.

Authors:  Nicoleta Antone; Darya Kizub; Julie Gralow; Jo Anne Zujewski; Allison Dvaladze
Journal:  JCO Glob Oncol       Date:  2021-04

2.  Impact of Time to Initiation of Treatment on the Quality of Life of Women with Breast Cancer.

Authors:  Magdalena Konieczny; Elżbieta Cipora; Wojciech Roczniak; Magdalena Babuśka-Roczniak; Marek Wojtaszek
Journal:  Int J Environ Res Public Health       Date:  2020-11-11       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.